Parkinson Disease Psychosis
Neurology
3
Pipeline Programs
2
Companies
3
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
2
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
PIMAVANSERINApproved
pimavanserin
Unknown Companyoral
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Acadia PharmaceuticalsSAN DIEGO, CA
2 programs1
PimavanserinPhase 41 trial
Real-world, non-interventionalN/A1 trial
Active Trials
VP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Acadia PharmaceuticalsPimavanserin
Vanda PharmaceuticalsIloperidone
Acadia PharmaceuticalsReal-world, non-interventional
Clinical Trials (3)
Total enrollment: 793 patients across 3 trials
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
Start: Feb 2020Est. completion: Apr 202229 patients
Phase 4Completed
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Start: Jun 2022Est. completion: Nov 20230
Phase 2Withdrawn
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
Start: Mar 2017Est. completion: Mar 2021764 patients
N/ATerminated
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
7h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
7h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
7h ago
Director of Finance
CoMind
London, UK
7h ago
Electronics Engineering Manager
CoMind
London, UK
7h ago
Director of Information Technology
Zavation Medical Products
7h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space